Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 5/2004

01-04-2004 | Therapy In Practice

Management of Insomnia in Patients with Chronic Pain Conditions

Authors: Prof. Frederic Stiefel, Daniele Stagno

Published in: CNS Drugs | Issue 5/2004

Login to get access

Abstract

The management of insomnia in patients experiencing chronic pain requires careful evaluation, good diagnostic skills, familiarity with cognitive-behavioural interventions and a sound knowledge of pharmacological treatments. Sleep disorders are characterised by a circular interrelationship with chronic pain such that pain leads to sleep disorders and sleep disorders increase the perception of pain. Sleep disorders in individuals with chronic pain remain under-reported, under-diagnosed and under-treated, which may lead — together with the individual’s emotional, cognitive and behavioural maladaptive responses — to the frequent development of chronic sleep disorders. The moderately positive relationship between pain severity and sleep complaints, and the specificity of pain-related arousal and mediating variables such as depression, illustrate that insomnia in relation to chronic pain is multifaceted and poorly understood. This may explain the limited success of the available treatments.
This article discusses the evaluation of patients with chronic pain and insomnia and the available pharmacological and nonpharmacological interventions to manage the sleep disorder. Non-pharmacological interventions should not be considered as single interventions, but in association with one another. Some non-pharmacological interventions especially the cognitive and behavioural approaches, can be easily implemented in general practice (e.g. stimulus control, sleep restriction, imagery training and progressive muscle relaxation). Hypnotics are routinely prescribed in the medically ill, regardless of their adverse effects; however, their long-term efficacy is not supported by robust evidence. Antidepressants provide an interesting alternative to hypnotics, since they can improve pain perception as well as sleep disorders in selected patients. Sedative antipsychotics can be considered for sleep disturbances in those patients exhibiting psychotic features, or for those with contraindications to benzodiazepines. Low doses of sedative antipsychotics may improve chronic insomnia in the elderly. However, no intervention is likely to be effective unless a good physician-patient relationship is developed.
Literature
1.
Bixler EO, Kales A, Soldatos CR, et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979; 136(10): 1257–62PubMed
2.
International classification of sleep disorders. In: American Sleep Disorders Association, editor. Diagnostic and coding manual. Rochester (MN): Am Sleep Disorders Association, 1997
3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: AmericanPsychiatric Association, 2000
4.
Sateia MJ, Doghramji K, Hauri PJ, et al. Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep 2000; 23(2): 243–308PubMed
5.
Holmgren A, Wise M, Boukoms A. Pain management. In: Wise M, Rundell RJ, editors. The American psychiatric publishing textbook of consultation-liaison psychiatry. Washington, DC: American Psychiatric Publishing Textbook, 2002: 989–1011
6.
7.
Lamberg L. Chronic pain linked with poor sleep; exploration of causes and treatment. JAMA 1999; 281(8): 691–2PubMedCrossRef
8.
Ancoli-Israel S. Epidemiology of sleep disorders. Clin Geriatr Med 1989; 5(2): 347–62PubMed
9.
National Sleep Foundation. Sleep in America: a national surveyof US adults. Princeton (NJ): The Gallup Organizations, 1991
10.
11.
Atkinson JH, Slater MA, Grant I, et al. Depressed mood in chronic low back pain: relationship with stressful life events. Pain 1988; 35(1): 47–55PubMedCrossRef
12.
Pilowski I, Townley M. Sleep disturbance in pain clinic patients. Pain 1985; 23(1): 27–33CrossRef
13.
Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med 1990; 89(3): 357–62PubMedCrossRef
14.
Healey ES, Kales A, Monroe LJ, et al. Onset of insomnia: role of life-stress events. Psychosom Med 1981; 43(5): 439–51PubMed
15.
Edinger JD, Stout AL, Hoelscher TJ. Cluster analysis of insomniacs’ MMPI profiles: relation of subtypes to sleep history and treatment outcome. Psychosom Med 1988; 50(1): 77–87PubMed
16.
Lawrence CC, Gilbert CJ, Peters WP. Evaluation of symptom distress in a bone marrow transplant outpatient environment. Ann Pharmacother 1996; 30(9): 941–5PubMed
17.
Smith MT, Perlis ML, Carmody TP, et al. Presleep cognitions in patients with insomnia secondary to chronic pain. J Behav Med 2001; 24(1): 93–114PubMedCrossRef
18.
Wilson KG, Eriksson MY, D’Eon JL, et al. Major depression and insomnia in chronic pain. Clin J Pain 2002; 18(2): 77–83PubMedCrossRef
19.
Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000; 23(1): 1–13PubMedCrossRef
20.
Currie SR, Wilson KG, Curran D. Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain. J Behav Med 2002; 25(2): 135–53PubMedCrossRef
21.
Currie SR, Wilson KG, Pontefract AJ, et al. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000; 68(3): 407–16PubMedCrossRef
22.
Smith MT, Perlis ML, Haythornwaite JA. Suicidal ideation in outpatients with chronic musculoskeletal pain: an exploratory study of the role of sleep onset insomnia and pain intensity. Clin J Pain 2004; 20(2): 111–8PubMedCrossRef
23.
Schneider-Helmert D, Whitehouse I, Kumar A, et al. Insomnia and alpha sleep in chronic non-organic pain as compared to primary insomnia. Neuropsychobiology 2001; 43(1): 54–8PubMedCrossRef
24.
Stroud MW, Thorn BE, Jensen MP, et al. The relation between pain beliefs, negative thoughts, and psychological functioning in chronic pain. Pain 2000; 84(2–3): 347–52PubMedCrossRef
25.
Wittig RM, Zorick FJ, Blumer D, et al. Disturbed sleep in patients complaining of chronic pain. J Nerv Ment Dis 1982; 170(7): 429–31PubMedCrossRef
26.
Nicassio PM, Wallston KA. Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis. J Abnorm Psychol 1992; 101(3): 514–20PubMedCrossRef
27.
Savar K, Arikan M, Yontem T. Sleep quality in chronic pain patients. Can J Psychiatry 2002; 47(9): 844–8
28.
McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002; 7(2): 75–9PubMed
29.
Simms RW. Field guide to soft tissue pain: diagnosis and management. Philadelphia: Lippincott Williams & Wilkins, 2001
30.
31.
Moldofsky H. Fibromyalgia, sleep disorder and chronic fatigue syndrome. Ciba Found Symp 1993; 173: 262–71PubMed
32.
Parker AJ, Wessely S, Cleare AJ. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001; 31(8): 1331–45PubMedCrossRef
33.
Pollmacher T, Mullington J, Korth C, et al. Influence of host defense activation on sleep in humans. Adv Neuroimmunol 1995; 5(2): 155–69PubMedCrossRef
34.
Smith GR. The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry 1992; 14(4): 265–72PubMedCrossRef
35.
Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46(2): 177–84PubMedCrossRef
36.
Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998; 14(4): 311–4PubMedCrossRef
37.
Gamsa A. Is emotional disturbance a precipitator or a consequence of chronic pain? Pain 1990; 42(2): 183–95PubMedCrossRef
38.
Wilson KG, Watson ST, Currie SR. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain. Pain 1998; 75(1): 75–84PubMedCrossRef
39.
Cochinov HM, Breitbart W, editors. Handbook of psychiatry in palliative medecine. New York: Oxford University Press, 2000
40.
41.
Meagher DJ, O’Hanlon D, O’Mahony E, et al. Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci 2000; 12(1): 51–6PubMed
42.
Landis CA, Robinson CR, Helms C, et al. Differential effects of acetylsalicylic acid and acetaminophen on sleep abnormalities in a rat chronic pain model. Brain Res 1989; 488(1–2): 195–201PubMedCrossRef
43.
Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989; 7(5): 479–91PubMedCrossRef
44.
Reite M, Buysse D, Reynolds C, et al. The use of polysomnography in the evaluation of insomnia. Sleep 1995; 18(1): 58–70PubMed
45.
Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis ofbenzodiazepine use in the treatment of insomnia. CMAJ 2000; 162(2): 225–38PubMed
46.
Zammit GK, Weiner G, Damato N, et al. Quality of life in people with insomnia. Sleep 1999; 22Suppl. 2: s379–85PubMed
47.
Schramm E, Hohagen F, Grasshoff U, et al. Test-retest reliabilityand validity of the structured interview for sleep disorders according to DSM-III-R. Am J Psychiatry 1993; 150(6): 867–72PubMed
48.
Buysse DJ, Reynolds III CF, Houck PR, et al. Age of illness onset and sleep EEG variables in elderly depressives. Biol Psychiatry 1988; 24(3): 355–9PubMedCrossRef
49.
Buysse DJ, Reynolds III CF, Monk TH, et al. Quantification ofsubjective sleep quality in healthy elderly men and womenusing the Pittsburgh Sleep Quality Index (PSQI). Sleep 1991; 14(4): 331–8PubMed
50.
Douglass A, Carskadon M, Houser R. Historical database, questionnaires,sleep and life cycle diaries. In: Miles L, Broughton R, editors. Medical monitoring in the home and work environment. New York: The Raven Press, 1990
51.
Morin CM. Psychological assessment and management. In:Morin CM, editor. Insomnia. New York: The Guilford Press,1993
52.
Hauri P, Fisher J. Persistent psychophysiologic (learned) insomnia. Sleep 1986; 9(1): 38–53PubMed
53.
Knab B, Engel RR. Perception of waking and sleeping: possibleimplications for the evaluation of insomnia. Sleep 1988; 11(3): 265–72PubMed
54.
Pollak CP, Perlick D, Linsner JP. Daily sleep reports andcircadian rest-activity cycles of elderly community residents with insomnia. Biol Psychiatry 1992; 32(11): 1019–27PubMedCrossRef
55.
Chambers MJ, Kim JY. The role of state-trait anxiety in insomniaand daytime restedness. Behav Med 1993; 19(1): 42–6PubMedCrossRef
56.
Brooks III JO, Friedman L, Bliwise DL, et al. Use of the wristactigraph to study insomnia in older adults. Sleep 1993; 16(2):151–5PubMed
57.
Friedman L, Benson K, Noda A, et al. An actigraphic comparisonof sleep restriction and sleep hygiene treatments for insomniain older adults. J Geriatr Psychiatry Neurol 2000; 13(1):17–27PubMedCrossRef
58.
Krahn LE, Lin SC, Wisbey J, et al. Assessing sleep in psychiatricinpatients: nurse and patient reports versus wrist actigraphy. Ann Clin Psychiatry 1997; 9(4): 203–10PubMed
59.
Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliabilityand validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 2002; 53(3): 737–40PubMedCrossRef
60.
Chesson AL Jr, Murphy PW, Arnold CL, et al. Presentation andreading level of sleep brochures: are they appropriate for sleepdisorders patients? Sleep 1998; 21(4): 406–12PubMed
61.
Morin CM, Kowatch RA, Wade JB. Behavioral management of sleep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatry 1989; 20(4): 295–302PubMedCrossRef
62.
Perlis ML, Sharpe M, Smith MS, et al. Behavioral treatment ofinsomnia: treatment outcome and the relevance of medical andpsychiatric morbidity. J Behav Med 2001; 24(3): 281–96PubMedCrossRef
63.
Chesson AL Jr, Anderson WM, Littner M, et al. Practiceparameters for the nonpharmacologic treatment of chronicinsomnia: an American Academy of Sleep Medicine report: Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22(8): 1128–33PubMed
64.
Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologictreatment of chronic insomnia: an American Academy of Sleep Medicine Review. Sleep 1999; 22(8): 1134–56PubMed
65.
Holbrook AM, Crowther R, Lotter A, et al. The diagnosis andmanagement of insomnia in clinical practice: a practical evidence-basedapproach. CMAJ 2000; 162(2): 216–20PubMed
66.
Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159(1): 5–11PubMedCrossRef
67.
National Commission on Sleep Disorder Research. Wake upAmerica: a national sleep alert: report of the National Commissionon Sleep Disorders Research. Palo Alto (CA): Departmentof Health and Human Services (DHHS), 1993
68.
Sackett DL. Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol 1993; 9(6): 487–9PubMed
69.
Hohagen F, Rink K, Kappler C, et al. Prevalence and treatment of insomnia in general practice: a longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993; 242(6): 329–36PubMedCrossRef
70.
Stiefel F, Berney A, Mazzocato C. Psychopharmacology insupportive care in cancer: a review for the clinician: I. Benzodiazepines.Support Care Cancer 1999; 7(6): 379–85CrossRef
71.
Greenblatt DJ, Shader RI. Dependence, tolerance, and addictionto benzodiazepines: clinical and pharmakinetic considerations. Drug Metab Rev 1978; 8(1): 13–28PubMedCrossRef
72.
Berney A, Stiefel F, Mazzocato C, et al. Psychopharmacologyin supportive care of cancer: a review for the clinician: III.Antidepressants. Support Care Cancer 2000; 8: 278–86PubMed
73.
McCracken LM, Iverson GL. Predicting complaints of impairedcognitive functionning in patients with chronic pain. J Pain Symptom Manage 2001; 21(5): 392–6PubMedCrossRef
74.
Wysowski DK, Schober SE, Wise RP, et al. Mortality attributedto misuse of psychoactive drugs, 1979–88. Public Health Rep 1993; 108(5): 565–70PubMed
75.
Wysowski DK, Barash D. Adverse behavioral reactions attributedto triazolam in the Food and Drug Administration’s Spontaneous Reporting System. Arch Intern Med 1991; 151(10):2003–8PubMedCrossRef
76.
Wysowski DK, Baum C. Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch Intern Med 1991; 151(9): 1779–83PubMedCrossRef
77.
Hättenschwiler J, Hatzinger M. Diagnostic des troubles du sommeil. Schweiz Med Forum 2001; 1(11): 265–76
78.
Portenoy R. Adjuvant analgesics in pain management. In: MacDonal dL, editor. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford University Press, 1998: 361–90
79.
Magni G. The use of antidepressants in the treatment of chronic pain: a review of the current evidence. Drugs 1991; 42(5): 730–48PubMedCrossRef
80.
Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49(2): 205–19PubMedCrossRef
81.
Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37(4): 589–96PubMedCrossRef
82.
Breitbart W. Psychotropic adjuvant analgesics for pain in cancer and AIDS. Psychooncology 1998; 7(4): 333–45PubMedCrossRef
83.
Mazzocato C, Stiefel F, Buclin T, et al. Psychopharmacology insupportive care of cancer: a review for the clinician: II. Neuroleptics. J Support Care Cancer 2000; 8: 89–97CrossRef
84.
Bloomfield S, Simard-Savoy S, Bernier J, et al. Comparative analgesic activity of levopromazine and morphine in patients with chronic pain. Can Med Assoc J 1964; (90): 1156-9
85.
Beaver WT, Wallenstein SL, Houde RW, et al. A comparison of the analgesic effects of methotrimeprazine and morphine in patients with cancer. Clin Pharmacol Ther 1966; 7(4): 436–46PubMed
86.
Davidsen O, Lindeneg O, Walsh M. Analgesic treatment with levomepromazine in acute myocardial infarction. A randomized clinical trial. Acta Med Scand 1979; 205(3): 191–4
87.
Lasagna L, DeKornfeld T. Methotrimeprazine, a new phenothiazine derivative with analgesic properties. JAMA 1961; (178): 887-90
88.
Morgan MY. The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol 1995; 30(6): 771–4PubMed
89.
Ather SA, Shaw SH, Stoker MJ. A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly. Acta Psychiatr Scand Suppl 1986; 329: 81–91PubMedCrossRef
90.
Dehlin O. Hypnotic effect of chlormethiazole in geriatric patients during long-term treatment. Acta Psychiatr Scand Suppl 1986; 329: 112–5PubMedCrossRef
91.
Gray PA, Park GR. Chlormethiazole sedation for critically ill patients in renal failure. Anaesthesia 1989; 44(11): 913–5PubMedCrossRef
92.
Overstall PW, Oldman PN. A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing 1987; 16(1): 45–51PubMedCrossRef
93.
Buclin T, Mazzocato C, Berney A, et al. Psychopharmacology in supportive care of cancer: a review for the clinician: IV Other psychotropic agents. Support Care Cancer 2001; 99: 213–22
94.
Zhdanova IV, Lynch HJ, Wurtman RJ. Melatonin: a sleep-promoting hormone. Sleep 1997; 20(10): 899–907PubMed
95.
Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57(5): 552–8PubMedCrossRef
96.
Lissoni P, Paolorossi F, Tancini G, et al. Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 1996; 32A(8): 1340–3PubMedCrossRef
Metadata
Title
Management of Insomnia in Patients with Chronic Pain Conditions
Authors
Prof. Frederic Stiefel
Daniele Stagno
Publication date
01-04-2004
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 5/2004
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200418050-00002